Bayer Schering Pharma named and shamed over UK Code

The UK unit of German drugmaker Bayer Schering Pharma has been "named  and shamed" by the Prescription Medicines Code of Practice Authority,  over a complaint concerning the alleged marketing of a product in  Britain by overseas affiliates, prior to the drug's marketing  authorization. The Authority said the offenses occurred "on more than  one occasion, did not prominently acknowledge sponsorship of a paid for  supplement and did not present up-to-date data in the supplement."

Bayer was ruled in breach of the following clauses of the Code:

- clause 2 - bringing discredit upon and reducing confidence in the  pharmaceutical industry;